Line 28: | Line 28: | ||
<a href="https://2016.igem.org/Team:MIT/Experiments/Recombinases"> | <a href="https://2016.igem.org/Team:MIT/Experiments/Recombinases"> | ||
<img src="https://static.igem.org/mediawiki/2016/e/e2/T--MIT--recombinasesbutton.svg" alt="Recombinases" > | <img src="https://static.igem.org/mediawiki/2016/e/e2/T--MIT--recombinasesbutton.svg" alt="Recombinases" > | ||
− | <span class="text-content"><span><br><br><br><br><br><br>Read more about how we | + | <span class="text-content"><span><br><br><br><br><br><br>Read more about how we characterized recombinases that could give a circuit memory across a cycle<br><br></span></span> |
</a> | </a> | ||
</li></ul><br> | </li></ul><br> |
Revision as of 02:52, 17 October 2016
This diagnostic process can be expedited with synthetic biological tools that sense the following molecular markers in endometrial biopsy samples.
-
Read more about how we created synthetic promoters to respond to this disease marker
-
Read more about how we characterized miRNA profiles in model cells under varying conditions
-
Read more about how we characterized recombinases that could give a circuit memory across a cycle